{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P35354",
      "entity_text" : "cox-2",
      "entity_type" : "protein"
    },
    "participant_a" : [ {
      "in_model" : true,
      "identifier" : "uniprot:Q53ET0",
      "entity_text" : "CRTC2",
      "entity_type" : "protein"
    }, {
      "in_model" : true,
      "identifier" : "be:CREB",
      "entity_text" : "CREB",
      "entity_type" : "family"
    } ],
    "hypothesis_information" : false
  },
  "verbose_text" : "We found that rapamycin treatment promoted the interaction between CRTC2 and CREB (XREF_FIG), induced CREB binding to the cox-2 promoter, and enhanced luciferase activity of the cox-2 promoter (XREF_FIG) in preadipocytes.",
  "reading_complete" : "2020-08-08T12:07:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T12:04:46Z",
  "trigger" : "enhanced",
  "evidence" : [ "CRTC2 and CREB ( XREF_FIG ), induced CREB binding to the cox-2 promoter                                              , and enhanced luciferase activity of the cox-2" ],
  "pmc_id" : "6287973",
  "score" : 0
}